Editorial: Sexual dimorphism in autoimmune and immune-dysregulated diseases
C. Alex Colvert,Melissa A. Cunningham
DOI: https://doi.org/10.3389/fimmu.2024.1531757
IF: 7.3
2024-12-07
Frontiers in Immunology
Abstract:The final, formatted version of the article will be published soon. You have multiple emails registered with Frontiers: Please enter your email address: If you already have an account, please login You don't have a Frontiers account ? You can register here In 2014, the National Institutes of Health (NIH) implemented policy that specified sex as a biological variable (SABV) be considered in all research designs involving vertebrate animal and human studies. Prior to this, scientists often incorporated only male sex into scientific research (1,2). Although it is important that SABV be investigated in all areas of health-related research, it is particularly important that sex be considered in reeearch related to immunity and autoimmunity since women have increased incidence of autoimmune diseases compared to men (3). The research topic "Sexual Dimorphism in Autoimmune and Immune-dysregulated Diseases" serves to help advance the understanding of how sex chromosomes and sex hormones influence autoimmune and immune-dysregulated diseases.Autoimmune and immune-dysregulated diseases are thought to arise due to a combination of genetic and environmental factors (such as infections and pollutants) that result in overactivation of the immune system (3). Robert G. Lahita discusses how microRNA (miRNA), genetics and epigenetics, estrogen (E2), prolactin, progesterone (P4), and androgens modulate autoimmunity in his review, "Sex and gender influence on immunity and autoimmunity." Lahita ultimately concludes that the female predisposition for most autoimmune diseases remains unelucidated but is likely due to a combination of the genetics of the X chromosome, hormonal regulation of immune cells, and sex hormones affecting epigenetics. Systemic Lupus Erythematous (SLE) is an autoimmune disease characterized by autoantibody formation and immune complex deposition in target organs. SLE predominates in women, with nine women affected for every one man, and patients living with SLE are at an increased risk for cardiovascular disease (CVD)(4). In the article "Cardiac and vascular complications in lupus: Is there a role for sex?" Corker et. al discuss the potential mechanisms of sex and sex hormones in the development of CVD in SLE.With regard to sex, male patients with SLE tend to have a more severe disease state that involves renal disease compared to women; this could be due to low testosterone levels in men with SLE. They discuss a clinical study by Hill et in their conceptual analysis, they extensively review the effects of sex on incidence and severity in actively induced EAE vs. spontaneous EAE vs. adoptive transfer EAE. The authors note that the species/strain, EAE-inducing antigen, and the differences/similarities observed between males and females all greatly impact the phenotype. They also explore cells, molecules and pathways that exhibit sex differences in EAE. Lastly, they discuss the implications of hormones and pregnancy in EAE. They conclude that among animal models, the effects of sex in EAE vary substantially (7).In apparent contrast, Guillain Barre syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CDIP) are autoimmune diseases that show predominance in males and prevalence increases with age. Characterized by demyelination and axonal pathology, GBS is usually preceded by illness, infection, trauma, or surgery. GBS and CDIP are unlike other autoimmune diseases in that there is no clear target antigen or HLA association (8). McCombe et. al explore possible mechanisms for the sexual dimorphism seen in GBS and CIDP. They postulate that the sex differences in GBS and CDIP could be due to males becoming more susceptible to immune dysfunction with age moreso than females, which may contribute to the male predominance.In the final article of the collection, Gao et. al evaluate the association between systemic immunity-inflammatory index (SII) and sex hormones in children and adolescents. Using weighted multiple regression analyses, they found a negative correlation between SII and sex-hormone binding globulin (SHBG) in male participants (mean age 12.32 +/-3.95 years). In female participants, a negative correlation was observed between SII and T2, SHBG, and ratio of T2 to estradiol. Using subgroup analyses and interaction tests based on diabetes status, body mass index, and puberty index, they discovered that SII did not have a significant correlation with these subgroups as opposed to females, where a consistent association was seen. These results suggest that SII may predict possible risks of sex hormone disorders, setting the groundwork required for preventative strategies against such disorders through SII surveillance (9).Collectively, these articles evaluate the pervasiveness of sex and sex hormones in autoimmune and immune-dysregulated diseases. This research topic highlights the importance of investig -Abstract Truncated-
immunology